WealthTrust Fairport LLC Sells 1,040 Shares of Express Scripts Holding (ESRX)

WealthTrust Fairport LLC lessened its holdings in Express Scripts Holding (NASDAQ:ESRX) by 11.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,332 shares of the company’s stock after selling 1,040 shares during the period. WealthTrust Fairport LLC’s holdings in Express Scripts were worth $622,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. SeaCrest Wealth Management LLC acquired a new position in Express Scripts in the fourth quarter valued at approximately $105,000. Bank of Nova Scotia Trust Co. purchased a new stake in Express Scripts in the third quarter valued at approximately $120,000. Monroe Bank & Trust MI increased its position in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares during the period. Harvest Fund Management Co. Ltd purchased a new stake in shares of Express Scripts during the fourth quarter worth $183,000. Finally, Nelson Roberts Investment Advisors LLC purchased a new stake in shares of Express Scripts during the third quarter worth $193,000. Hedge funds and other institutional investors own 89.08% of the company’s stock.

In other news, VP Glen D. Stettin sold 3,449 shares of the company’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The disclosure for this sale can be found here. Insiders have sold a total of 21,896 shares of company stock valued at $1,617,903 over the last three months. 0.68% of the stock is currently owned by company insiders.

Express Scripts Holding (NASDAQ ESRX) traded down $0.30 on Wednesday, hitting $76.70. 8,362,708 shares of the stock traded hands, compared to its average volume of 6,260,000. The company has a market cap of $43,220.00, a P/E ratio of 9.91, a P/E/G ratio of 0.96 and a beta of 0.94. Express Scripts Holding has a one year low of $55.80 and a one year high of $85.07. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.07. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business had revenue of $25.38 billion during the quarter, compared to the consensus estimate of $25.07 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. sell-side analysts expect that Express Scripts Holding will post 9.35 earnings per share for the current year.

Express Scripts announced that its board has initiated a share buyback plan on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Several research firms recently commented on ESRX. BidaskClub lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday, February 14th. SunTrust Banks set a $82.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research note on Thursday, December 14th. Jefferies Group downgraded shares of Express Scripts from a “buy” rating to a “hold” rating and set a $91.00 target price for the company. in a research note on Thursday, March 8th. Maxim Group raised their price objective on shares of Express Scripts from $87.00 to $101.00 in a research report on Wednesday, February 28th. Finally, Royal Bank of Canada set a $68.00 target price on shares of Express Scripts and gave the company a “hold” rating in a report on Friday, December 15th. Three investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating to the company. Express Scripts currently has a consensus rating of “Hold” and a consensus price target of $81.97.

COPYRIGHT VIOLATION NOTICE: “WealthTrust Fairport LLC Sells 1,040 Shares of Express Scripts Holding (ESRX)” was originally posted by Equities Focus and is owned by of Equities Focus. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.equitiesfocus.com/2018/03/14/express-scripts-holding-esrx-stake-lessened-by-wealthtrust-fairport-llc.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply